1. Home
  2. IMNM vs KELYA Comparison

IMNM vs KELYA Comparison

Compare IMNM & KELYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMNM
  • KELYA
  • Stock Information
  • Founded
  • IMNM 2006
  • KELYA 1946
  • Country
  • IMNM United States
  • KELYA United States
  • Employees
  • IMNM N/A
  • KELYA 5570
  • Industry
  • IMNM Medicinal Chemicals and Botanical Products
  • KELYA Professional Services
  • Sector
  • IMNM Health Care
  • KELYA Consumer Discretionary
  • Exchange
  • IMNM Nasdaq
  • KELYA Nasdaq
  • Market Cap
  • IMNM 542.6M
  • KELYA 401.2M
  • IPO Year
  • IMNM 2020
  • KELYA N/A
  • Fundamental
  • Price
  • IMNM $7.91
  • KELYA $11.18
  • Analyst Decision
  • IMNM Strong Buy
  • KELYA Buy
  • Analyst Count
  • IMNM 6
  • KELYA 1
  • Target Price
  • IMNM $26.00
  • KELYA $25.00
  • AVG Volume (30 Days)
  • IMNM 1.7M
  • KELYA 316.7K
  • Earning Date
  • IMNM 05-13-2025
  • KELYA 05-08-2025
  • Dividend Yield
  • IMNM N/A
  • KELYA 2.68%
  • EPS Growth
  • IMNM N/A
  • KELYA N/A
  • EPS
  • IMNM N/A
  • KELYA N/A
  • Revenue
  • IMNM $9,041,000.00
  • KELYA $4,331,800,000.00
  • Revenue This Year
  • IMNM N/A
  • KELYA $9.54
  • Revenue Next Year
  • IMNM $1,259.12
  • KELYA $3.92
  • P/E Ratio
  • IMNM N/A
  • KELYA N/A
  • Revenue Growth
  • IMNM N/A
  • KELYA N/A
  • 52 Week Low
  • IMNM $5.15
  • KELYA $11.00
  • 52 Week High
  • IMNM $19.07
  • KELYA $24.25
  • Technical
  • Relative Strength Index (RSI)
  • IMNM 55.28
  • KELYA 30.60
  • Support Level
  • IMNM $6.96
  • KELYA $11.00
  • Resistance Level
  • IMNM $7.56
  • KELYA $11.64
  • Average True Range (ATR)
  • IMNM 0.69
  • KELYA 0.54
  • MACD
  • IMNM 0.26
  • KELYA -0.12
  • Stochastic Oscillator
  • IMNM 98.22
  • KELYA 7.69

About IMNM Immunome Inc.

Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which it can efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious diseases, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP), and others.

About KELYA Kelly Services Inc.

Kelly Services Inc is a provider of workforce solutions and consulting and staffing services. The company's operations are divided into five business segments namely Professional & Industrial, Science, Engineering & Technology, Education, Outsourcing & Consulting, and International. Other than OCG, each segment delivers talent through staffing services, permanent placement, or outcome-based services. OCG segment delivers talent solutions including managed service providers, payroll process outsourcing, recruitment process outsourcing, and talent advisory services. International also delivers RPO talent solutions within its local markets. The majority of revenue is derived from Professional & Industrial.

Share on Social Networks: